Tarcocimab and KSI-501 bring the best of both worlds – high immediacy and high durability – at the same time and in the same biologic therapy 28 1 mg ABC ® Platform- based medicines 4 mg + Tarcocimab For immediacy: unconjugated protein For durability: ABC ® (conjugated) protein 1 mg 3.5 mg + KSI-501 1.5 mg